Granzyme B is a serine protease predominantly expressed in cytotoxic lymphocytes, including natural killer (NK) cells and cytotoxic T cells, where it plays a critical role in inducing apoptosis in target cells. It functions by entering target cells through pores formed by perforin and activating caspases that lead to programmed cell death. Due to its central role in immune responses, inflammation, cancer, and autoimmune diseases, accurate measurement of Granzyme B levels and activity is essential for both basic research and clinical applications.
Applications of Granzyme B Assay Kits
- Immunology Research: To study cytotoxic lymphocyte function, T cell-mediated cytotoxicity, and NK cell activity.
- Cancer Research: To investigate tumor immune surveillance and mechanisms of immune evasion, including resistance to Granzyme B-induced apoptosis.
- Autoimmune and Inflammatory Diseases: To explore Granzyme B’s role in tissue damage and inflammation.
- Drug Discovery: Screening for inhibitors of Granzyme B as potential therapeutics for conditions such as graft-versus-host disease or autoimmune disorders.
- Clinical Biomarker Studies: Quantifying Granzyme B levels in body fluids (plasma, serum, wound fluid) and tissue extracts to correlate with disease states.
Technical Features and Performance
- Sample Types: Assays accommodate diverse samples including cell culture supernatants, plasma, serum, tissue extracts, and purified enzyme preparations.
- Sensitivity: ELISA kits can detect Granzyme B at picogram per milliliter levels, while activity assays detect enzyme activity down to low nanogram per milliliter ranges or lower depending on incubation times.
- Assay Formats: Kits are available in 96- or 384-well plate formats, supporting high throughput screening with minimal sample volume.
- Assay Time: Immunoassays like HTRF require minimal hands-on time and no washing steps, enabling rapid results at room temperature, while activity assays may require incubation periods ranging from a few hours to overnight depending on sensitivity needs.
Biological and Clinical Significance of Granzyme B
Granzyme B’s classical role involves inducing apoptosis in virus-infected or malignant cells, facilitating immune defense. However, recent research reveals broader functions, including perforin-independent mechanisms affecting sublethal DNA damage responses and modulating immune and inflammatory pathways. Dysregulation of Granzyme B activity has implications in autoimmunity, cancer progression, and neurotoxicity, making it a valuable target for therapeutic intervention and biomarker development.
Granzyme B assay kits, encompassing both protein quantification and enzymatic activity measurement, provide essential tools for investigating the multifaceted roles of Granzyme B in health and disease. Advances in assay design, including homogeneous detection formats and signal amplification strategies, have enhanced sensitivity, specificity, and throughput, facilitating diverse applications from basic immunological research to drug discovery and clinical diagnostics.
